IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
30 hedge funds and large institutions have $14.3M invested in Insight Molecular Diagnostics Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 26 reducing their positions, and 21 closing their positions.
Holders
30
Holders Change
-17
Holders Change %
-36.17%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
–
Reduced
26
Closed
21
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Comerica Bank
Dallas,
Texas
|
$116 |
2 |
2
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$3 |
Top Sellers
1 |
BC
1
Broadwood Capital
New York
|
$7.83M |
2 |
AIC
2
AWM Investment Company
New York
|
$2.36M |
3 |
PVI
3
Pura Vida Investments
New York
|
$2.05M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$749K |
5 |
5
Morgan Stanley
New York
|
$435K |